The DATIROS brand, founded in 2005 (Switzerland), from 19 sister brands and 2214 competing brands. DATIROS is owned by BASILEA PHARMA, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0011432447. DATIROS belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
BASILEA PHARMA
(DATIROS)
over 5 years*
CHF 37.49